DrugPatentWatch Database Preview
Physiological Effect: Increased Coagulation Factor VIII Activity
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Drugs with Physiological Effect: Increased Coagulation Factor VIII Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | STIMATE (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 020355-002 | Oct 24, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Ferring Pharms Inc | STIMATE | desmopressin acetate | SPRAY, METERED;NASAL | 020355-001 | Mar 7, 1994 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Alyvant | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Alyvant | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Alyvant | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Alyvant | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Alyvant | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
